Knopp Biosciences knoppbiosciences.com


Public lists: Pharma Startups (4733)

Knopp Biosciences is a drug discovery and development company focused on delivering treatments for unmet medical needs through experience and partnership. The company's clinical and preclinical programs focus on mechanisms of mitochondrial energetics and its lead compound, dexpramipexole, is currently in Phase 3 clinical development for amyotrophic lateral sclerosis. Additional programs include dexpramipexole combination therapy for Parkinson's disease and the discovery of ion channel modulators...Show all

Knopp Biosciences is a drug discovery and development company focused on delivering treatments for unmet medical needs through experience and partnership. The company's clinical and preclinical programs focus on mechanisms of mitochondrial energetics...Show all

Company (Alive / Active)

Phone: 412-488-1776

Fax:

2100 Wharton Street
Suite 615
Pittsburgh, 15203
Pennsylvania, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Knopp Biosciences $167.4M Dec 5, 2017
Xenon Pharmaceuticals $134.7M Nov 5, 2014
Active Pass Pharmaceuticals $0M Aug 7, 2018
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Knopp Biosciences Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 10 investors

Competitors

Company Status Description Investors
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Compositions and methods for treating amyotrophic lateral sclerosis in responders Apr 20, 2017 May 01, 2018 Patent
Benzoimidazol-1,2-yl amides as kv7 channel activators Oct 31, 2016 Mar 13, 2018 Patent
Compositions and methods of using (r)-pramipexole Oct 08, 2015 Dec 26, 2017 Patent
Compositions and methods for treating chronic urticaria Aug 13, 2014 Sep 19, 2017 Patent
Compositions and methods for treating amyotrophic lateral sclerosis in responders Feb 28, 2014 May 30, 2017 Patent
See all 30 patents